ghk-cu oral clinical trial Beauty GHK-Cu Peptides Before and After:
Description
Retatrutide monotherapy achieved 24.2% weight reduction in phase 2 trials, while cagrilintide combined with semaglutide (CagriSema) reached 22.7%

Angelini explains

References Malfait F

Mech Ageing Dev 120(1):141149
